1,6:3,4-Dianhydro-2-O-tosyl-β-D-galactopyranose
Original price was: $795.00.$395.00Current price is: $395.00.
Catalog Number: B2027222 (1 g)
1,6:3,4-Dianhydro-2-O-tosyl-β-D-galactopyranose is a bicyclic carbohydrate derivative featuring fused oxirane ring structures and a p-toluenesulfonyl (tosyl) ester leaving group. It serves as a specialized, highly reactive chiral intermediate in carbohydrate chemistry, particularly for the stereoselective synthesis of modified sugars and fluorinated analogs. Supplied as a pure chemical reagent, this compound is widely utilized in organic synthesis, glycosylation studies, and biochemical research applications. Custom bulk amounts of this product are available upon request.
Live Chat enquiry about this product at: Live Chat.
In stock
Product Description
1,6:3,4-Dianhydro-2-O-tosyl-β-D-galactopyranose
Catalog number: B2027222
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 1 g
Molecular Weight or Concentration: 234.25
Supplied as: Powder
Storage: NA
Keywords: 1,6:3,4-Dianhydro-2-O-p-toluenesulfonyl-β-D-galactopyranose, 1,6:3,4-Dianhydro-2-O-(4-toluenesulfonyl)-β-D-galactopyranose
References:
1. Holden HM, Rayment I, Thoden JB. Structure and function of enzymes involved in the Leloir pathway for galactose metabolism. Journal of Biological Chemistry. 2003;278(45):43885-43888.
2. Frey PA. The Leloir pathway: a century of biochemistry and genetics. FASEB Journal. 1996;10(4):461-470.
3. Timson DJ. The structural biology of galactosemia. International Journal of Molecular Sciences. 2016;17(7):1028.
4. Cerny M, Stanek J. 1,6-Anhydro-beta-D-glucopyranose (levoglucosan) and its derivatives. Advances in Carbohydrate Chemistry and Biochemistry. 1977;34:23-177.
5. Coelho AI, Berry GT, Rubio-Gozalbo ME. Galactosemia: old metabolite, new implications. Journal of Inherited Metabolic Disease. 2015;38(3):431-443.
6. Leloir LF. The enzymatic transformation of uridine diphosphate glucose into a galactose derivative. Archives of Biochemistry and Biophysics. 1951;33(2):186-190.
7. McCorvie TJ, Timson DJ. The structural and physiological basis of galactosemia. Biochimica et Biophysica Acta. 2011;1812(11):1385-1398.
8. Fridovich-Keil JL. Galactosemia: the good, the bad, and the unknown. Journal of Cellular Physiology. 2006;209(3):701-705.
9. Isselbacher KJ, Anderson EP, Kurahashi K, Kalckar HM. Congenital galactosemia, a single enzymatic block in galactose metabolism. Science. 1956;123(3198):635-636.
10. Leslie ND. Insights into the pathogenesis of galactosemia. Annual Review of Nutrition. 2003;23(1):59-80.
1,6:3,4-Dianhydro-2-O-tosyl-β-D-galactopyranose
Products Related to 1,6:3,4-Dianhydro-2-O-tosyl-β-D-galactopyranose can be found at Carbohydrates
Additional Information
| Weight | 0.15 oz |
|---|---|
| Dimensions | 2 × 0.5 × 0.5 in |
Several ways to order Molecular Depot products:
1- Order online using our website’s automated shopping cart and checkout system (available 24/7).
2- Order by email: info@moleculardepot.com (we accept electronic PO, available 24/7).
3- Order by Live Chat.
4- Order by Fax: 1-858-437-9884 (available 24/7).






